Business
ADAR1 Announces ISS Recommends Keros Therapeutics Stockholders WITHHOLD Votes from Directors Dr. Mary Ann Gray and Dr. Alpna Seth
ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1" or "We"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding shares, today announced that leading independent proxy advisory firm Institutional Shareholder Services Inc. ("ISS") has recommended that Keros stockholders WITHHOLD votes from incumbent directors Dr. Mary Ann Gray and Dr. Alpna Seth at the Company's upcoming Annual Meeting of S
About this update from Keros Therapeutics, Inc.
[{"type":"text","content":"ADAR1 Urges Board to Release Strategic Review Results Before, Not After, Annual Meeting","length":87,"tagName":"p","attribs":{}},{"type":"text","content":"AUSTIN, Texas, May 21, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1" or "We"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding shares, today announced that leading independent proxy advisory firm Institutional Shareholder Services Inc. ("ISS") has recommended that Keros stockholders WITHHOLD votes from incumbent directors Dr. Mary Ann Gray and Dr. Alpna Seth at the Company's upcoming Annual Meeting of Stockholders (the "Annual Meeting"), scheduled for June 4, 2025.","length":675,"tagName":"p"},{"type":"image","alt":"ADAR1 Capital Management","displaySize":"","headline":null,"caption":"ADAR1 Capital Management","className":"","disableSlideshowImg":false,"size":{"original":{"width":200,"height":200,"url":"https://media.zenfs.com/en/prnewswire.com/248d792a037d8f5dfd03eb073721e3e0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_d4p1egj.agSOCFHJ64ksw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTM2MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/248d792a037d8f5dfd03eb073721e3e0","width":200,"height":200}},"href":"https://mma.prnewswire.com/media/2692663/adar1_capital_management_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"In its report, ISS raised serious concerns regarding the Company's governance and concluded that greater accountability at Keros is needed.","length":143,"tagName":"p"},{"type":"text","content":""We are pleased that ISS has recognized the need for improved governance and oversight at Keros," said Dr. Daniel Schneeberger, Managing Partner of ADAR1. "We believe this recommendation validates the concerns we have raised regarding the Company's Board and supports our view that stockholders would benefit from fresh, independent directors."","length":368,"tagName":"p"},{"type":"text","content":"ADAR1 also noted that the Company announced that it intends to disclose the outcome of its strategic review process five days after the Annual Meeting. Stockholders are being asked to cast critical votes without knowin...